298 related articles for article (PubMed ID: 32080152)
21. Number of evaluated lymph nodes and positive lymph nodes, lymph node ratio, and log odds evaluation in early-stage pancreatic ductal adenocarcinoma: numerology or valid indicators of patient outcome?
Lahat G; Lubezky N; Gerstenhaber F; Nizri E; Gysi M; Rozenek M; Goichman Y; Nachmany I; Nakache R; Wolf I; Klausner JM
World J Surg Oncol; 2016 Sep; 14(1):254. PubMed ID: 27687517
[TBL] [Abstract][Full Text] [Related]
22. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
[TBL] [Abstract][Full Text] [Related]
23. Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.
Li HJ; Chen YT; Yuan SQ
Medicine (Baltimore); 2018 Aug; 97(34):e12094. PubMed ID: 30142869
[TBL] [Abstract][Full Text] [Related]
24. Lymph node ratio is an independent prognostic factor after resection of periampullary malignancies: data from a tertiary referral center in the middle East.
Shamseddine AI; Mukherji D; Melki C; Elias E; Eloubeidi M; Dimassi H; Khalife M; Abou-Alfa G; O'Reilly E; Faraj W
Am J Clin Oncol; 2014 Feb; 37(1):13-8. PubMed ID: 23111358
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification?
Linder S; Holmberg M; Engstrand J; Ghorbani P; Sparrelid E
Surg Oncol; 2022 May; 41():101735. PubMed ID: 35287096
[TBL] [Abstract][Full Text] [Related]
26. A Comprehensive Assessment of Accurate Lymph Node Staging and Preoperative Detection in Resected Pancreatic Cancer.
Masuda T; Dann AM; Elliott IA; Baba H; Kim S; Sedarat A; Muthusamy VR; Girgis MD; Joe Hines O; Reber HA; Donahue TR
J Gastrointest Surg; 2018 Feb; 22(2):295-302. PubMed ID: 29043580
[TBL] [Abstract][Full Text] [Related]
27. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy.
Fischer LK; Katz MH; Lee SM; Liu L; Wang H; Varadhachary GR; Wolff RA; Lee JE; Maitra A; Roland CL; Fleming JB; Estrella J; Rashid A; Wang H
Histopathology; 2016 Jan; 68(2):210-20. PubMed ID: 25945396
[TBL] [Abstract][Full Text] [Related]
28. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
[TBL] [Abstract][Full Text] [Related]
29. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas.
Fujita T; Nakagohri T; Gotohda N; Takahashi S; Konishi M; Kojima M; Kinoshita T
Pancreas; 2010 Jan; 39(1):e48-54. PubMed ID: 19910836
[TBL] [Abstract][Full Text] [Related]
31. Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?
Konstantinidis IT; Deshpande V; Zheng H; Wargo JA; Fernandez-del Castillo C; Thayer SP; Androutsopoulos V; Lauwers GY; Warshaw AL; Ferrone CR
J Gastrointest Surg; 2010 Feb; 14(2):261-7. PubMed ID: 19937477
[TBL] [Abstract][Full Text] [Related]
32. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
Serrano PE; Cleary SP; Dhani N; Kim PT; Greig PD; Leung K; Moulton CA; Gallinger S; Wei AC
Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
[TBL] [Abstract][Full Text] [Related]
33. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
[TBL] [Abstract][Full Text] [Related]
34. The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer.
Guo S; Shang M; Dong Z; Zhang J; Wang Y; Zhao Y
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e117-e124. PubMed ID: 32762113
[TBL] [Abstract][Full Text] [Related]
35. Common hepatic artery lymph node metastasis in pancreatic ductal adenocarcinoma: an analysis of actual survival.
Kuo S; Ventin M; Sato H; Harrison JM; Okuda Y; Qadan M; Ferrone CR; Lillemoe KD; Fernandez-Del Castillo C
J Gastrointest Surg; 2024 May; 28(5):672-678. PubMed ID: 38704205
[TBL] [Abstract][Full Text] [Related]
36. A systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma.
Elshaer M; Gravante G; Kosmin M; Riaz A; Al-Bahrani A
Ann R Coll Surg Engl; 2017 Feb; 99(2):101-106. PubMed ID: 27869496
[TBL] [Abstract][Full Text] [Related]
37. Lymph node evaluation for treatment of adenocarcinoma of the pancreas.
Marmor S; Burke EE; Portschy PR; Virnig BA; Jensen EH; Tuttle TM
Surg Oncol; 2015 Sep; 24(3):284-91. PubMed ID: 26303825
[TBL] [Abstract][Full Text] [Related]
38. Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.
Malleo G; Maggino L; Qadan M; Marchegiani G; Ferrone CR; Paiella S; Luchini C; Mino-Kenudson M; Capelli P; Scarpa A; Lillemoe KD; Bassi C; Castillo CF; Salvia R
Ann Surg; 2022 Nov; 276(5):e518-e526. PubMed ID: 33177357
[TBL] [Abstract][Full Text] [Related]
39. Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes.
Wasif N; Bentrem DJ; Farrell JJ; Ko CY; Hines OJ; Reber HA; Tomlinson JS
Cancer; 2010 Jul; 116(14):3369-77. PubMed ID: 20564064
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Lymph Node Ratio Association With Long-term Patient Survival After Surgery for Node-Positive Merkel Cell Carcinoma.
Cheraghlou S; Agogo GO; Girardi M
JAMA Dermatol; 2019 Jul; 155(7):803-811. PubMed ID: 30825411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
